Tau is developing innovative products to fundamentally change the way cancer is treated. These products span a wide spectrum of cancer indications. It is Tau’s goal to usher in a new, safer, and better standard of care for all solid tumor cancers.
Tau’s platform technology Interlaced Therapy™ has the possibility to increase both the safety and efficacy of standard chemotherapy. As a result, it may be possible to tailor this targeted therapy to an individual’s needs, potentially allowing for lower doses of chemotherapy and a reduction of its harmful side effects.
